摘要
目的探讨分析对恶性心律失常患者采用胺碘酮联合门冬氨酸钾镁注射液进行治疗的临床疗效。方法选取本院2019年6月-2021年6月收治的90例恶性心律失常患者进行此次研究,按照患者入院时间进行分组,其中先入院45例作为参照组采用单纯胺碘酮治疗,后入院的45例作为研究组联合门冬氨酸钾镁注射液进行治疗,观察对两组的治疗效果。结果比较两组的治疗效果、不良反应发生率、血清镁、血清钾指标、心电图检查结果、治疗后的复发率,研究组均优于参照组(P<0.05)。结论根据本次研究的结果可以确认,能够很好地控制患者的临床症状,改善患者的心功能,防止患者出现不良反应问题,长久地控制患者的病情,降低患者的死亡率,值得在临床上大力推广。
Objective To investigate and analyze the clinical effect of amiodarone combined with potassium magnesium asparate injection in the treatment of patients with malignant arrhythmia.Methods In our hospital during June 2019 to June 2021 treated 90 cases of malignant arrhythmia patients in this study,according to the time of patients admitted to hospital group,the first hospital 45 cases as control group adopts pure amiodarone treatment,45 cases admitted to hospital after as a joint team nmda potassium magnesium injection treatment,observation of the curative effect of two groups.Results The treatment effect,the incidence of adverse reactions,serum magnesium,serum potassium,electrocardiogram results and recurrence rate after treatment were compared between the two groups,the study group was better than the reference group(P<0.05).Conclusion According to the results of this study,it can be confirmed that the clinical symptoms of patients can be well controlled,the cardiac function of patients can be improved,the adverse reactions of patients can be prevented,the disease of patients can be controlled for a long time,and the mortality of patients can be reduced,which is worth promoting in clinical practice.
作者
张智华
ZHANG Zhihua(Yangchun People’s Hospital,Yangjiang,Guangdong 529600)
出处
《智慧健康》
2022年第2期130-132,139,共4页
Smart Healthcare
关键词
恶性心律失常
胺碘酮
门冬氨酸钾镁注射液
临床疗效
对比分析
Malignant arrhythmia
Amiodarone
Potassium and magnesium aspartate injection
Clinical efficacy
Comparison and analysis
